AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D.,…
Month: September 2023
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D.,…
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the…
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
Promising exarafenib combination data in NRAS mutant melanoma; intend to select two doses in the…
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY,…
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY,…
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a…
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a…
Histogen Announces Board Approval of Complete Liquidation and Dissolution
SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), today announced that…
Histogen Announces Board Approval of Complete Liquidation and Dissolution
SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), today announced that…
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Timber Pharmaceuticals, Inc. (“Timber”…
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously…
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Timber Pharmaceuticals, Inc. (“Timber”…
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously…
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage…
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company)…
Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023
DURHAM, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and…
Mercury Introduces the First Space-qualified FPGA Processing Board Powered by AMD Xilinx Versal® Technology
Mercury’s SCFE6933 Mercury’s SCFE6933 is a radiation-tolerant, 6U SpaceVPX board that will make high-performance computing…
Enablence Announces New 4-Channel Course Wavelength Division Multiplexing (CWDM) Optical Demux Devices
Compact, Lower-Cost, Low Insertion Loss Transceivers Target Datacom Applications Fremont, California–(Newsfile Corp. – September 18,…